Exact Mass: 365.1375

Exact Mass Matches: 365.1375

Found 101 metabolites which its exact mass value is equals to given mass value 365.1375, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Acetylbialaphos

N-Acetylbialaphos; N-Acetylphosphinothricin tripeptide

C13H24N3O7P (365.1352)


   

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

N-[(2R,3S,4R)-3-Hydroxy-2-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-yl]ethanimidate

C14H23NO10 (365.1322)


2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl- D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] 2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl- D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087).

   

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

N-[(2R,3S,4R)-4-Hydroxy-2-(hydroxymethyl)-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-yl]ethanimidate

C14H23NO10 (365.1322)


2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] 2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087).

   

Ampicilloyl

2-{1-[(2-amino-1-hydroxy-2-phenylethylidene)amino]-2-oxopropyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylate

C17H23N3O4S (365.1409)


   

Riddelliine N-oxide

4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0^{14,17}]heptadec-11-en-14-ium-14-olate

C18H23NO7 (365.1474)


   

cucoline

(1R,9S,10S)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one;hydrochloride

C19H24ClNO4 (365.1394)


Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   

cucoline

(1R,9S,10S)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one;hydrochloride

C19H23NO4.HCl (365.1394)


Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   
   
   

Erucifoline N-oxide

Erucifoline N-oxide

C18H23NO7 (365.1474)


A pyrrolizine alkaloid that is erucifoline in which the tertiary amino function has been oxidised to the corresponding N-oxide. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2256

   

Seneciocannabine

Seneciocannabine

C18H23NO7 (365.1474)


   

9-Hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.04,8.016,19]nonadec-13-ene-3,6,10-trione

9-Hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.04,8.016,19]nonadec-13-ene-3,6,10-trione

C18H23NO7 (365.1474)


   
   
   
   
   

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine

C14H27N3O4S2 (365.1443)


   

N2-(Pyrene-1-yl)methyl-guanine

N2-(Pyrene-1-yl)methyl-guanine

C22H15N5O1 (365.1277)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

C14H23NO10 (365.1322)


   

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

C14H23NO10 (365.1322)


   

N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine

N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine

C19H24ClNO4 (365.1394)


   

1H-Indole,1-methyl-3-[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-(9CI)

1H-Indole,1-methyl-3-[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-(9CI)

C20H19N3O4 (365.1375)


   

(S,E)-1-phenyl-N-(4-(trifluoromethyl)benzylidene)-2-(trimethylsilyloxy)ethanamine

(S,E)-1-phenyl-N-(4-(trifluoromethyl)benzylidene)-2-(trimethylsilyloxy)ethanamine

C19H22F3NOSi (365.1423)


   

Cloperastine hydrochloride

Cloperastine hydrochloride

C20H25Cl2NO (365.1313)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

1-butyl-2,3,3-trimethylbenzo[e]indol-3-ium,perchlorate

1-butyl-2,3,3-trimethylbenzo[e]indol-3-ium,perchlorate

C19H24ClNO4 (365.1394)


   

5-tritylpyridine-2-carboxylic acid

5-tritylpyridine-2-carboxylic acid

C25H19NO2 (365.1416)


   

H-GABA-OBzl.TosOH

H-GABA-OBzl.TosOH

C18H23NO5S (365.1297)


   

1-[2-[(S)-(4-Chlorophenyl)phenylmethoxy]ethyl]piperidine hydrochloride

1-[2-[(S)-(4-Chlorophenyl)phenylmethoxy]ethyl]piperidine hydrochloride

C20H24ClNO.HCl (365.1313)


   

4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline

4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline

C20H19N3O4 (365.1375)


   

1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-

1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-

C19H19N5OS (365.131)


JNJ-1661010 (Takeda-25) a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 34 and 33 nM for rat FAAH and human FAAH, respectively. JNJ-1661010 can cross the blood-brain barrier and used as broad-spectrum analgesics[1][2].

   

Riddelliine N-oxide

Riddelliine N-oxide

C18H23NO7 (365.1474)


A pyrrolizine alkaloid that is 13,19-didehydrosenecionane bearing two additional hydroxy substituents at positions 12 and 18, two additional oxo groups at positions 11 and 16 and an N-oxido substituent.

   

methyl 9-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid

methyl 9-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid

C14H23NO10 (365.1322)


   

3-({[(3s)-3,4-Dihydroxybutyl]oxy}amino)-1h,2h-2,3-Biindol-2-One

3-({[(3s)-3,4-Dihydroxybutyl]oxy}amino)-1h,2h-2,3-Biindol-2-One

C20H19N3O4 (365.1375)


   

(2z,3e)-2,3-Biindole-2,3(1h,1h)-Dione 3-{o-[(3r)-3,4-Dihydroxybutyl]oxime}

(2z,3e)-2,3-Biindole-2,3(1h,1h)-Dione 3-{o-[(3r)-3,4-Dihydroxybutyl]oxime}

C20H19N3O4 (365.1375)


   

Indolebutyryl-glucose

Indolebutyryl-glucose

C18H23NO7 (365.1474)


   

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

C14H27N3O4S2 (365.1443)


   

2-[1-[(2-Amino-2-phenylacetyl)amino]-2-oxopropyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

2-[1-[(2-Amino-2-phenylacetyl)amino]-2-oxopropyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

C17H23N3O4S (365.1409)


   

(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H23NO7 (365.1474)


   

N-[(E)-(3,4-dimethoxyphenyl)methylideneamino]-2-quinolin-8-yloxyacetamide

N-[(E)-(3,4-dimethoxyphenyl)methylideneamino]-2-quinolin-8-yloxyacetamide

C20H19N3O4 (365.1375)


   

4-(4-Ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester

4-(4-Ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester

C20H19N3O4 (365.1375)


   

N-(4-acetamidophenyl)-4-(1,3-dioxo-2-isoindolyl)butanamide

N-(4-acetamidophenyl)-4-(1,3-dioxo-2-isoindolyl)butanamide

C20H19N3O4 (365.1375)


   
   
   
   

jacozine N-oxide

jacozine N-oxide

C18H23NO7 (365.1474)


A pyrrolizine alkaloid that is jacozine in which the tertiary amino function has been oxidised to the corresponding N-oxide.

   

[(1S)-7-methoxy-2-methyl-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-7-methoxy-2-methyl-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C17H23N3O4S (365.1409)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-[4-[2-[(2E)-2-(pyridin-4-ylmethylidene)hydrazinyl]-1,3-thiazol-4-yl]phenyl]butanamide

N-[4-[2-[(2E)-2-(pyridin-4-ylmethylidene)hydrazinyl]-1,3-thiazol-4-yl]phenyl]butanamide

C19H19N5OS (365.131)


   

1-O-[4-(1H-Indol-3-yl)butanoyl]-D-glucopyranose

1-O-[4-(1H-Indol-3-yl)butanoyl]-D-glucopyranose

C18H23NO7 (365.1474)


   

Ethyl 2-methyl-4,5-dioxo-1-phenyl-3-phenyldiazenylpyrrolidine-2-carboxylate

Ethyl 2-methyl-4,5-dioxo-1-phenyl-3-phenyldiazenylpyrrolidine-2-carboxylate

C20H19N3O4 (365.1375)


   

(5R,7S,9Z,12R,15R,18R)-9-ethylidene-7-(hydroxymethyl)-5-methyl-15-oxido-3,6,11-trioxa-15-azoniatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione

(5R,7S,9Z,12R,15R,18R)-9-ethylidene-7-(hydroxymethyl)-5-methyl-15-oxido-3,6,11-trioxa-15-azoniatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione

C18H23NO7 (365.1474)


   

Arecaidine but-2-ynyl ester (tosylate)

Arecaidine but-2-ynyl ester (tosylate)

C18H23NO5S (365.1297)


Arecaidine but-2-ynyl ester tosylate (ABET) is a selective mAChR M2 agonist that dose-dependently decreases mean arterial pressure and heart rate in rats. Arecaidine but-2-ynyl ester tosylate can be used for cardiovascular disease research[1][2]. Arecaidine but-2-ynyl ester (tosylate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

C18H23NO7 (365.1474)


   

5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

C20H19N3O4 (365.1375)


   

methyl 5-{3-hydroxy-9-oxo-1h,2h-pyrrolo[2,1-b]quinazolin-3-yl}-2-(methylamino)benzoate

methyl 5-{3-hydroxy-9-oxo-1h,2h-pyrrolo[2,1-b]quinazolin-3-yl}-2-(methylamino)benzoate

C20H19N3O4 (365.1375)


   

4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

(4r,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4r,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

C18H23NO7 (365.1474)


   

(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-4,10-dioxo-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-en-15-ium-15-olate

(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-4,10-dioxo-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-en-15-ium-15-olate

C18H23NO7 (365.1474)


   

(1r,20r)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione

(1r,20r)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione

C18H23NO7 (365.1474)


   

(1'r,3s,6's,7'r,17'r)-7'-hydroxy-3,7'-dimethyldispiro[oxirane-2,4'-[2,9]dioxa-[14]azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-6',2''-oxiran]-11'-ene-3',8'-dione

(1'r,3s,6's,7'r,17'r)-7'-hydroxy-3,7'-dimethyldispiro[oxirane-2,4'-[2,9]dioxa-[14]azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-6',2''-oxiran]-11'-ene-3',8'-dione

C18H23NO7 (365.1474)


   

(3s,6s)-3-[(2ar)-2ah,3h-[1,2]dioxeto[3,4-b]indol-7b-ylmethyl]-6-benzyl-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(2ar)-2ah,3h-[1,2]dioxeto[3,4-b]indol-7b-ylmethyl]-6-benzyl-3,6-dihydropyrazine-2,5-diol

C20H19N3O4 (365.1375)


   

(1r,5s,8s,10s)-5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

(1r,5s,8s,10s)-5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

C20H19N3O4 (365.1375)


   

1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

C20H19N3O4 (365.1375)


   
   

(1r,4r,5r,8s,9s,19r)-9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

(1r,4r,5r,8s,9s,19r)-9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

C18H23NO7 (365.1474)


   

(1s,20s)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione

(1s,20s)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione

C18H23NO7 (365.1474)


   

4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methyl-3h-imidazol-2-imine

4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methyl-3h-imidazol-2-imine

C20H19N3O4 (365.1375)


   

(4s,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4s,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

(1s,4r)-1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

(1s,4r)-1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

C20H19N3O4 (365.1375)